Artificial Cells, Nanomedicine, and Biotechnology (ACNB)

Artificial Cells, Nanomedicine, and Biotechnology is an interdisciplinary journal, publishing high-quality open access research at the convergence of artificial cells, nanomedicine and health-related biotechnology. The journal places an emphasis on original research that demonstrates game-changing and disruptive technologies, new concepts and innovative experimental approaches. Articles featuring translational approaches such as clinical implementation may also be published in the journal. For work to be published it must be of significant interest to the artificial cell , nano health and biotechnology communities and must fall under one of the key subject areas listed below: Artificial cells: synthetic biology, synthetic organelles, build-a-cell artificial exosomes/extracellular vesicles synthetic genomics, self-assembly, origins of life application of artificial cells as: - biotherapeutics and immunotherapeutic (including stem cell therapy) - blood substitutes oxygen therapeutics - novel carriers for therapeutics (e.g. vaccines, drugs) bio-immunosorbents therapy

Artificial Cells, Nanomedicine, and Biotechnology (ACNB) is :-

• International, Peer-Reviewed, Open Access, Refereed, synthetic biology, synthetic organelles, build-a-cell, artificial exosomes/extracellular vesicles, synthetic genomics, self-assembly, origins of life, biotherapeutics, bio-immunosorbents therapy , Online or Print , Continuously Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2169-1401, E-ISSN: 2169-141X, Established: 1973, Impact Factor: 4.5
• Provides Crossref DOI

• Indexed in: Scopus, WoS

• Not indexed in DOAJ, PubMed, UGC CARE